ANIMAL tumours used for screening procedures in the selection of cytotoxic agents with potential clinical application are in general rapidly growing, and often have high growth fractions, whereas clinically many of the more common solid tumours appear to be relatively slow growing, probably with growth fractions considerably less than those found in rodent tumours. It is hoped that the human xenograft tumour may provide a practical experimental model which will simulate the human disease to a greater degree in its cellular proliferation kinetics. There is therefore a need for more data on the growth patterns of human primary tumours growing in immune-deprived mice, to establish whether the xenograft retains the growth characteristics observed in the clinic, and to assess whether these characteristics are maintained during serial passage. Six human colorectal tumour xenografts have been established in immune-deprived mice, and their growth characteristics studied for up to 10 transplant generations.
MATERIALS AND METHODS
Immune deprivation of mice.-Four-weekold male and female CBA/lac mice were immune-deprived as previously described (Houghton, Houghton and Taylor, 1977) .
Tumour implantation.-Tumour tissue was obtained at operation and implants were completed within 6 h of removal from the patient. Tissue was placed in ice-cold Medium 199 containing benzyl penicillin sodium (200 u/ml) and streptomycin sulphate (100 ,ug/ml) and transported to the laboratory on ice. Potentially viable sections were dissected from the invading tumour margin for implantation. Pieces 8 mm3 were cut and bilateral implants made s.c. into the flanks of each of 20 male and 20 female immunedeprived mice. Due to the possibility of bacterial contamination from these specimens, the mice were each injected i.p. with 75 mg/kg penicillin and 25 mg/kg streptomycin 30 min before tumour implantation. This considered sufficient to achieve high antibiotic blood levels. On Passage 1 no animals subsequently died from gross bacterial infection induced by tumour inoculation. Passaged tumours were serially transplanted upon reaching a diameter of 2 cm, tumour pieces from male and female mice being retransplanted bilaterally into hosts of the same sex.
For the percentage-labelled-mitoses technique, 4 tumour implants were made per mouse, 2 specimens being implanted into each flank.
Estimation of tumour volume.-Two perpendicular diameters wAere measured for each tumour at wAeekly intervals, using vernier calipers. Estimations of tumour volume wNere made by substitution in the formula -r/6 X d3, where d is the mean tumour diameter (Kopper and Steel, 1975) .
Analysis of cell kinetic parameters.-The technique of labelled mitoses was used. Mice each bearing 4 tumours of less than 1 cm diameter were injected i.p. with 25 ,uCi 6-3H-thymidine (sp. act. 27 Ci/mmol; Radiochemical Centre, Amersham). Whole tumours were excised at various times for up to 72 h after injection, the two tumours from one flank being removed at any one time. Tumours were fixed in formol saline and autoradiographs were prepared according to the method of Pickard, Cobb and Steel (1975) .
Mitotic and labelling indices were estimated by counting the cells from 50 microscope fields (-5500 cells) using the first tumour from each series (either at 1 or 2 h). At least 75 metaphase or anaphase figures wNere scored in the estimation of the fraction of labelled mitoses. Background labelling was estimated as 2 grains/cell. Analysis of the data was performed by the optimizing computer program described by Steel and Hanes (1971) .
Cell-loss factor and growNth fraction were calculated by the method of Steel (1968) .
Tumour lines. The 6 human colorectal tumour xenograft lines, maintained in both male and female immune-deprived CBA/lac mice, have been described previously (Houghton and Taylor, 1977 
Cell-proliferation kinetics
The percentage-labelled-mitoses technique (PLM) was applied to GC3 tumours on Passages 3 and 10 in male mice. Tumour Line GC3 was selected for study, as the mean volume-doubling time calculated at 0 4 cm3 decreased from 11.1 to 6-6 days between Passages 3 and 10, and unless growth rates almost double between the passages selected for study, it is difficult to obtain from the PLM technique an indication of the nature of the observed changes (Dr G. G. Steel, personal communication The curves for the two passages are similar. In both cases, the first peaks are well defined, although the second peaks fall well below the 50%0 level, suggesting wide variations in intermitotic times for both passages. The distribution of intermitotic times calculated using the computer model is shown in Fig. 7 . Broad distributions are apparent, but the spread is similar for both the early and the laterpassage tumours. The computed cell-cycle (Welin et al., 1963) . Terz, Curutchet and Lawrence (1971) Lipkin, Bell and Sherlock (1963). Pickard et al. (1975) (Steel and Lamerton, 1966) .
Evidence has been presented that individual host mice at least partially influence the growth of implanted tumour pieces, and the rate of growth of established tumours. Within any one passage the growth rates of tumours maintained within the same host were similar, and this correlation was significant in each tumour line. It is possible that the extent of host influence on tumour growth rates may depend upon the extent of individual host immune-deprivation, which may in turn influence the rate of cell loss within a tumour. In addition, the numbers of single tumour takes decreased significantly upon passaging, and after Passage 1 in each tumour line the observed values differed significantly from those predicted from the binomial distribution. It is possible that the higher incidence of single takes on Passage 1 may be due to the balance between the ability of the implanted human tumour piece to withstand the initial period of hypoxic ischaemia until the tumour vasculature becomes established, and the effect of host residual immunity on the introduction of foreign material. It is probable that further transplants from an established tumour are able to survive this initial period of hypoxia (selection) and in these circumstances host defences may then be more important in the determination of tumour takes within individual host mice.
Irregular growth patterns were observed in some instances where the tumour growth rate decreased for a period of time before returning to a more rapid rate. Similar observations were made by Pickard et al. (1975) who also noted the occurrence of spontaneous regressions. The reason for such irregularities is not clear, although they should be considered especially during chemotherapeutic trials, and where growth delay is used as the sole criterion for assessment of drug efficacy.
In one tumour line studied in detail, namely GC3 maintained in male hosts, the increase in growth rate observed could be accounted for by a 10% decrease in the cell-loss factor between Passages 3 and 10. This appeared to occur without concomitant influence from a change in cell-cycle time, or growth fraction where the slight increase obtained was insufficient to account for the degree of change observed. It would seem unlikely, therefore, that selection of the fastest-growing cells had taken place. The possible cause for the decrease in cell loss during serial passage is not clear. A progressive decrease in tumour antigenicity may be responsible where there may be selection of the least antigenic cells or progressive coating of surface antigens by antibody, thus allowing less antigen to be exposed (Rees and Westwood, 1974) .
Results suggest that the cell-loss factor may in fact be the major kinetic change observed during serial passage, and this appears not to affect the chemosensitivity (Houghton and Houghton, unpublished) . It has been reported previously that this series of human colorectal tumour xenografts appears to maintain the histological, mucin-secreting and CEA-producing characteristics of the corresponding human primary tumours, in addition to the 222 maintenance of human lactate dehydrogenase and glucose-6-phosphate dehydrogenase isoenzyme patterns and a human chromosome constitution (Houghton, 1977; Houghton and Taylor, 1977) . Evidence to date suggests that even with continued serial passage over 2 to 3 years, these xenografts maintained in immunedeprived mice appear not to change appreciably from the primary human specimen.
